BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 16682107)

  • 1. Quetiapine-induced neuroleptic malignant syndrome in dementia with Lewy bodies: a case report.
    Kobayashi A; Kawanishi C; Matsumura T; Kato D; Furukawa R; Kishida I; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1170-2. PubMed ID: 16682107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias.
    Aarsland D; Perry R; Larsen JP; McKeith IG; O'Brien JT; Perry EK; Burn D; Ballard CG
    J Clin Psychiatry; 2005 May; 66(5):633-7. PubMed ID: 15889951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms.
    Baskys A
    J Clin Psychiatry; 2004; 65 Suppl 11():16-22. PubMed ID: 15264967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome secondary to quetiapine.
    Gortney JS; Fagan A; Kissack JC
    Ann Pharmacother; 2009 Apr; 43(4):785-91. PubMed ID: 19299325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies.
    Sechi G; Agnetti V; Masuri R; Deiana GA; Pugliatti M; Paulus KS; Rosati G
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Aug; 24(6):1043-51. PubMed ID: 11041543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study of neuroleptic malignant syndrome in the presenium and senium].
    Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
    Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia--common features and differences].
    Drach LM
    Med Monatsschr Pharm; 2011 Feb; 34(2):47-52; quiz 53-4. PubMed ID: 21428015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quetiapine treatment of psychotic symptoms and aggressive behavior in patients with dementia with Lewy bodies: a case series.
    Takahashi H; Yoshida K; Sugita T; Higuchi H; Shimizu T
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):549-53. PubMed ID: 12691793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
    Bottlender R; Jäger M; Hofschuster E; Dobmeier P; Möller HJ
    Pharmacopsychiatry; 2002 May; 35(3):119-21. PubMed ID: 12107858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of neuroleptic sensitivity in Lewy body disease with a false positive clinical diagnosis of Creutzfeldt-Jakob disease.
    Lemstra AW; Schoenmaker N; Rozemuller-Kwakkel AJ; van Gool WA
    Int J Geriatr Psychiatry; 2006 Nov; 21(11):1031-5. PubMed ID: 16955430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptics are associated with more severe tangle pathology in dementia with Lewy bodies.
    Ballard CG; Perry RH; McKeith IG; Perry EK
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):872-5. PubMed ID: 16116579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive effects of quetiapine in a patient with dementia with Lewy bodies.
    Rice T; Dobry Y; Wang E; Novakovic V; Sher L
    Psychogeriatrics; 2013 Mar; 13(1):52-7. PubMed ID: 23551413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dementia with Lewy bodies. Review of diagnosis and pharmacologic management.
    Frank C
    Can Fam Physician; 2003 Oct; 49():1304-11. PubMed ID: 14594099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of quetiapine in the treatment of behavioral and psychological symptoms of dementia.
    Onor ML; Saina M; Aguglia E
    Am J Alzheimers Dis Other Demen; 2006 Dec-2007 Jan; 21(6):448-53. PubMed ID: 17267378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical neuroleptic malignant syndrome with long-term clozapine.
    Corallo CE; Ernest D
    Crit Care Resusc; 2007 Dec; 9(4):338-40. PubMed ID: 18052897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunct treatment with levodopa in a patient with dementia with Lewy bodies, delusions and severe neuroleptic hypersensitivity syndrome.
    Majic T; Mell T; Heinz A; Rapp MA
    Int Psychogeriatr; 2010 Jun; 22(4):678-9. PubMed ID: 20199702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
    Paleacu D; Barak Y; Mirecky I; Mazeh D
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid onset of quetiapine-induced diabetic ketoacidosis in an elderly patient: a case report.
    Takahashi M; Ohishi S; Katsumi C; Moriya T; Miyaoka H
    Pharmacopsychiatry; 2005 Jul; 38(4):183-4. PubMed ID: 16025424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating neuropsychiatric symptoms in dementia with Lewy bodies: a randomized controlled-trial.
    Culo S; Mulsant BH; Rosen J; Mazumdar S; Blakesley RE; Houck PR; Pollock BG
    Alzheimer Dis Assoc Disord; 2010; 24(4):360-4. PubMed ID: 20625270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.